Compare NOAH & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NOAH | IART |
|---|---|---|
| Founded | 2005 | 1989 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 754.2M | 696.8M |
| IPO Year | 2010 | 1996 |
| Metric | NOAH | IART |
|---|---|---|
| Price | $11.29 | $9.44 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 7 |
| Target Price | $10.75 | ★ $14.50 |
| AVG Volume (30 Days) | 126.0K | ★ 769.4K |
| Earning Date | 03-24-2026 | 05-04-2026 |
| Dividend Yield | ★ 5.08% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $4.45 |
| Revenue Next Year | $3.79 | $3.40 |
| P/E Ratio | $13.29 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.67 | $8.70 |
| 52 Week High | $12.84 | $22.27 |
| Indicator | NOAH | IART |
|---|---|---|
| Relative Strength Index (RSI) | 42.30 | 40.09 |
| Support Level | $11.11 | N/A |
| Resistance Level | $11.34 | $14.14 |
| Average True Range (ATR) | 0.31 | 0.42 |
| MACD | -0.03 | 0.06 |
| Stochastic Oscillator | 35.19 | 69.44 |
Noah Holdings Ltd is a wealth management service provider offering comprehensive advisory services on investment and asset allocation, mainly for Mandarin-speaking high-net-worth (HNW) investors. The company's operating segments are Domestic public securities, Domestic asset management, Domestic insurance, Overseas wealth management, Overseas asset management, Overseas insurance and comprehensive services, and Headquarters. Maximum revenue is generated from its Domestic asset management business, which manages private equity funds, real estate equity funds, and private secondary products. The domestic asset management operations focus on managing primary market exits and cross-border ETF products in the secondary market. Geographically, it derives maximum revenue from Mainland China.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.